Use of natural language understanding to facilitate surgical de-escalation of axillary staging in patients with breast cancer.
Neil M CarletonGilan SaadawiPriscilla F McAuliffeAtilla SoranSteffi OesterreichAdrian V LeeEmilia J DiegoPublished in: medRxiv : the preprint server for health sciences (2024)
Natural language understanding (NLU) may be particularly well-equipped for enhanced data capture from the electronic health record (EHR) given its examination of both content- and context-driven extraction. We developed and applied a NLU model to examine rates of pathological node positivity (pN+) and rates of lymphedema to determine if omission of routine axillary staging could be extended to younger patients with ER+/cN0 disease. We found that rates of pN+ and arm lymphedema were similar between patients 55-69yo and ≥70yo, with rates of lymphedema exceeding rates of pN+ for clinical stage T1c and smaller disease. Data from our NLU model suggest that omission of SLNB might be extended beyond Choosing Wisely recommendations, limited to those over 70 years old, to all postmenopausal women with early-stage ER+/cN0 disease. These data support the recently-reported SOUND trial results and provide additional granularity to facilitate surgical de-escalation.
Keyphrases
- electronic health record
- lymph node
- early stage
- clinical decision support
- sentinel lymph node
- end stage renal disease
- autism spectrum disorder
- neoadjuvant chemotherapy
- clinical trial
- big data
- ejection fraction
- lymph node metastasis
- adverse drug
- open label
- pet ct
- randomized controlled trial
- squamous cell carcinoma
- chronic kidney disease
- machine learning
- deep learning
- study protocol
- endoplasmic reticulum
- body composition
- breast cancer cells
- phase ii
- patient reported outcomes
- prognostic factors
- locally advanced
- rectal cancer